FilingIndex
← The Wire
SDGRNasdaq

Schrodinger, Inc.

Pharmaceutical Preparations · DE · CIK 1490978

Schrödinger, Inc. transforms drug and material discovery with a physics-based computational platform

red 8-K · 90d⚡ Elevated coverage
$1.08B
Market cap
$17.39
Last close
+3.1%
1D
+14.2%
5D
2.0M
Volume
Price · last 39 sessions+34.8%
May 4L $11.95 · H $17.39Jun 29
112
Total filings
Jun 29, 2026
Last filing
12/31
Fiscal year end
8-KReg FD DisclosureJun 29, 20268-KExecutive Change · Shareholder VoteJun 23, 20268-KExecutive ChangeJun 8, 20268-KExecutive Change · Reg FD DisclosureMay 20, 202610-Q10-QMay 5, 20268-KResults of OperationsMay 5, 2026DEFA14ADEFA14AApr 28, 2026DEF 14ADEF 14AApr 28, 20268-KExecutive ChangeMar 12, 202610-K10-KFeb 25, 20268-KResults of OperationsFeb 25, 202610-Q10-QNov 5, 20258-KResults of OperationsNov 5, 20258-KExecutive ChangeSep 8, 202510-Q10-QAug 6, 20258-KResults of OperationsAug 6, 20258-KShareholder VoteJun 18, 20258-KExecutive ChangeMay 20, 20258-KCompany UpdateMay 19, 202510-Q10-QMay 7, 20258-KResults of OperationsMay 7, 2025DEFA14ADEFA14AApr 24, 2025DEF 14ADEF 14AApr 24, 20258-KCompany UpdateApr 11, 20258-KExecutive ChangeMar 10, 202510-K10-KFeb 26, 20258-KResults of OperationsFeb 26, 2025SC 13GSC 13GNov 13, 202410-Q10-QNov 12, 20248-KResults of OperationsNov 12, 20248-KMaterial AgreementNov 12, 20248-KMaterial AgreementSep 12, 202410-Q10-QJul 31, 20248-KResults of OperationsJul 31, 20248-KExecutive Change · Shareholder VoteJun 18, 2024DEFA14ADEFA14AMay 30, 202410-Q10-QMay 1, 20248-KResults of OperationsMay 1, 2024DEFA14ADEFA14AApr 25, 2024DEF 14ADEF 14AApr 25, 20248-KMaterial AgreementFeb 29, 202410-K10-KFeb 28, 20248-KResults of OperationsFeb 28, 202410-Q10-QNov 1, 20238-KResults of OperationsNov 1, 20238-K/AResults of OperationsAug 3, 202310-Q10-QAug 2, 20238-KResults of OperationsAug 2, 20238-KShareholder VoteJun 15, 20238-KMaterial AgreementMay 24, 2023424B5424B5May 24, 202310-Q10-QMay 4, 20238-KResults of OperationsMay 4, 2023DEFA14ADEFA14AApr 27, 2023DEF 14ADEF 14AApr 27, 20238-KBylaw AmendmentApr 13, 202310-K10-KFeb 28, 20238-KResults of OperationsFeb 28, 2023SC 13GSC 13GFeb 10, 2023SC 13GSC 13GFeb 3, 202310-Q10-QNov 3, 20228-KResults of OperationsNov 3, 20228-KExecutive ChangeAug 18, 202210-Q10-QAug 4, 20228-KResults of OperationsAug 4, 20228-KExecutive Change · Shareholder VoteJun 16, 2022DEFA14ADEFA14AJun 9, 2022DEFA14ADEFA14AMay 19, 20228-KExecutive ChangeMay 19, 202210-Q10-QMay 4, 20228-KResults of OperationsMay 4, 2022DEFA14ADEFA14AApr 29, 2022DEFA14ADEFA14AApr 28, 2022DEF 14ADEF 14AApr 28, 20228-KExecutive ChangeMar 2, 202210-K10-KFeb 24, 20228-KResults of OperationsFeb 24, 2022SC 13GSC 13GFeb 4, 20228-KExecutive ChangeDec 21, 202110-Q10-QNov 10, 2021

Insider Activity

In the 90 days to Mar 6, 2026: 7 sold $293K.

DateInsiderActionSharesPriceValue
Mar 6, 2026Herman JennyCAOSell608$12.84$8K
Mar 5, 2026Farid RamyPresident & CEOSell3,661$12.91$47K
Mar 5, 2026Jain RachitEVP & CFOSell1,631$12.90$21K
Mar 5, 2026Akinsanya KarenSee RemarksSell1,366$12.90$18K
Mar 5, 2026Lorton Kenneth PatrickEVP, CTO & COO, SoftwareSell1,222$12.90$16K
Mar 5, 2026Tran YvonneEVP, CLO & CPOSell1,094$12.90$14K
Mar 5, 2026Herman JennyCAOSell775$12.85$10K
Mar 4, 2026Abel Robert LorneSee RemarksSell1,300$12.81$17K
Mar 2, 2026Farid RamyPresident & CEOSell5,560$11.90$66K
Mar 2, 2026Akinsanya KarenSee RemarksSell2,206$11.99$26K
Feb 10, 2026Lorton Kenneth PatrickEVP, CTO & COO, SoftwareSell925$13.73$13K
Feb 10, 2026Tran YvonneEVP, CLO & CPOSell776$13.80$11K
Feb 10, 2026Herman JennyCAOSell752$13.79$10K
Feb 9, 2026Abel Robert LorneSee RemarksSell1,230$13.51$17K
Oct 16, 2025Dugan MargaretChief Medical OfficerSell1,395$21.07$29K

Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.

In the News

⚡ Elevated coverage

Coverage (30d): 1 reputable article · skews neutral.

Reputable outlets only (Reuters, WSJ, CNBC, Barron's, and peers). More on Google News ↗

Similar companies

Comparable business profile · signals at a glance